Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 219 articles:
HTML format
Text format



Single Articles


    January 2017
  1. ZHANG S, Deng Z, Yao C, Huang P, et al
    AT7867 Inhibits Human Colorectal Cancer Cells via AKT-Dependent and AKT-Independent Mechanisms.
    PLoS One. 2017;12:e0169585.
    PubMed     Text format     Abstract available


  2. HUANG WS, Kuo YH, Kuo HC, Hsieh MC, et al
    CIL-102-Induced Cell Cycle Arrest and Apoptosis in Colorectal Cancer Cells via Upregulation of p21 and GADD45.
    PLoS One. 2017;12:e0168989.
    PubMed     Text format     Abstract available


  3. LU M, Zessin AS, Glover W, Hsu DS, et al
    Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis.
    PLoS One. 2017;12:e0169439.
    PubMed     Text format     Abstract available


  4. WU R, Feng J, Yang Y, Dai C, et al
    Significance of Serum Total Oxidant/Antioxidant Status in Patients with Colorectal Cancer.
    PLoS One. 2017;12:e0170003.
    PubMed     Text format     Abstract available


  5. LI Y, Wang WY, Xiao JH, Xu F, et al
    Overexpression of Rad51 Predicts Poor Prognosis in Colorectal Cancer: Our Experience with 54 Patients.
    PLoS One. 2017;12:e0167868.
    PubMed     Text format     Abstract available


  6. FROUWS MA, Reimers MS, Swets M, Bastiaannet E, et al
    The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis.
    PLoS One. 2017;12:e0170775.
    PubMed     Text format     Abstract available


  7. QIN M, Zhang J, Xu C, Peng P, et al
    Knockdown of NIK and IKKbeta-Binding Protein (NIBP) Reduces Colorectal Cancer Metastasis through Down-Regulation of the Canonical NF-kappaBeta Signaling Pathway and Suppression of MAPK Signaling Mediated through ERK and JNK.
    PLoS One. 2017;12:e0170595.
    PubMed     Text format     Abstract available


  8. SOO HC, Chung FF, Lim KH, Yap VA, et al
    Cudraflavone C Induces Tumor-Specific Apoptosis in Colorectal Cancer Cells through Inhibition of the Phosphoinositide 3-Kinase (PI3K)-AKT Pathway.
    PLoS One. 2017;12:e0170551.
    PubMed     Text format     Abstract available


  9. KINAR Y, Akiva P, Choman E, Kariv R, et al
    Performance analysis of a machine learning flagging system used to identify a group of individuals at a high risk for colorectal cancer.
    PLoS One. 2017;12:e0171759.
    PubMed     Text format     Abstract available


  10. PENG Y, Yang H, Ye Q, Zhou H, et al
    Inhibition of peritoneal dissemination of colon cancer by hyperthermic CO2 insufflation: A novel approach to prevent intraperitoneal tumor spread.
    PLoS One. 2017;12:e0172097.
    PubMed     Text format     Abstract available


  11. ZHAI H, Shi Y, Chen X, Wang J, et al
    CacyBP/SIP promotes the proliferation of colon cancer cells.
    PLoS One. 2017;12:e0169959.
    PubMed     Text format     Abstract available


  12. FAN G, Zhang K, Yang X, Ding J, et al
    Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review.
    PLoS One. 2017;12:e0171991.
    PubMed     Text format     Abstract available


  13. ALI H, Bitar MS, Al Madhoun A, Marafie M, et al
    Functionally-focused algorithmic analysis of high resolution microarray-CGH genomic landscapes demonstrates comparable genomic copy number aberrations in MSI and MSS sporadic colorectal cancer.
    PLoS One. 2017;12:e0171690.
    PubMed     Text format     Abstract available


  14. ZERIOUH W, Nani A, Belarbi M, Dumont A, et al
    Phenolic extract from oleaster (Olea europaea var. Sylvestris) leaves reduces colon cancer growth and induces caspase-dependent apoptosis in colon cancer cells via the mitochondrial apoptotic pathway.
    PLoS One. 2017;12:e0170823.
    PubMed     Text format     Abstract available


  15. LI P, Xiao Z, Braciak TA, Ou Q, et al
    A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.
    PLoS One. 2017;12:e0172799.
    PubMed     Text format     Abstract available


  16. PRIETO I, Del Puerto-Nevado L, Gonzalez N, Portal-Nunez S, et al
    Colon cancer modulation by a diabetic environment: A single institutional experience.
    PLoS One. 2017;12:e0172300.
    PubMed     Text format     Abstract available


  17. KATHER JN, Zollner FG, Schad LR, Melchers SM, et al
    Identification of a characteristic vascular belt zone in human colorectal cancer.
    PLoS One. 2017;12:e0171378.
    PubMed     Text format     Abstract available


  18. WEBER L, Al-Refae K, Ebbert J, Jagers P, et al
    Activation of odorant receptor in colorectal cancer cells leads to inhibition of cell proliferation and apoptosis.
    PLoS One. 2017;12:e0172491.
    PubMed     Text format     Abstract available


  19. SARSHEKEH AM, Advani S, Overman MJ, Manyam G, et al
    Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer.
    PLoS One. 2017;12:e0173345.
    PubMed     Text format     Abstract available


  20. THEAN LF, Wong YH, Lo M, Loi C, et al
    Chromosome 19q13 disruption alters expressions of CYP2A7, MIA and MIA-RAB4B lncRNA and contributes to FAP-like phenotype in APC mutation-negative familial colorectal cancer patients.
    PLoS One. 2017;12:e0173772.
    PubMed     Text format     Abstract available


  21. TASHIRO T, Okuyama H, Endo H, Kawada K, et al
    In vivo and ex vivo cetuximab sensitivity assay using three-dimensional primary culture system to stratify KRAS mutant colorectal cancer.
    PLoS One. 2017;12:e0174151.
    PubMed     Text format     Abstract available


  22. GOEDE SL, Rabeneck L, van Ballegooijen M, Zauber AG, et al
    Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening.
    PLoS One. 2017;12:e0172864.
    PubMed     Text format     Abstract available


  23. CARLSON GE, Martin EW, Shirure VS, Malgor R, et al
    Dynamic biochemical tissue analysis detects functional L-selectin ligands on colon cancer tissues.
    PLoS One. 2017;12:e0173747.
    PubMed     Text format     Abstract available


  24. SHINKINS B, Nicholson BD, Primrose J, Perera R, et al
    The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial.
    PLoS One. 2017;12:e0171810.
    PubMed     Text format     Abstract available


  25. SIMICZYJEW A, Mazur AJ, Dratkiewicz E, Nowak D, et al
    Involvement of beta- and gamma-actin isoforms in actin cytoskeleton organization and migration abilities of bleb-forming human colon cancer cells.
    PLoS One. 2017;12:e0173709.
    PubMed     Text format     Abstract available


  26. HUANG WY, Ho CL, Lee CC, Hsiao CW, et al
    Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer.
    PLoS One. 2017;12:e0174280.
    PubMed     Text format     Abstract available


  27. YANG M, Xiao X, Xing X, Li X, et al
    KRAS and VEGF gene 3'-UTR single nucleotide polymorphisms predicted susceptibility in colorectal cancer.
    PLoS One. 2017;12:e0174140.
    PubMed     Text format     Abstract available


  28. WIEGERING A, Riegel J, Wagner J, Kunzmann V, et al
    The impact of pulmonary metastasectomy in patients with previously resected colorectal cancer liver metastases.
    PLoS One. 2017;12:e0173933.
    PubMed     Text format     Abstract available


  29. BERGER AW, Schwerdel D, Welz H, Marienfeld R, et al
    Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA.
    PLoS One. 2017;12:e0174308.
    PubMed     Text format     Abstract available


    January 2016
  30. PARK JY, Murakami T, Lee JY, Zhang Y, et al
    Fluorescent-Antibody Targeting of Insulin-Like Growth Factor-1 Receptor Visualizes Metastatic Human Colon Cancer in Orthotopic Mouse Models.
    PLoS One. 2016;11:e0146504.
    PubMed     Text format     Abstract available



  31. Correction: Association between Body Mass Index and Prognosis of Colorectal Cancer: A Meta-Analysis of Prospective Cohort Studies.
    PLoS One. 2016;11:e0147456.
    PubMed     Text format     Abstract available


  32. MARKOWITZ SD, Nock NL, Schmit SL, Stadler ZK, et al
    A Germline Variant on Chromosome 4q31.1 Associates with Susceptibility to Developing Colon Cancer Metastasis.
    PLoS One. 2016;11:e0146435.
    PubMed     Text format     Abstract available


  33. QURESHI-BAIG K, Ullmann P, Rodriguez F, Frasquilho S, et al
    What Do We Learn from Spheroid Culture Systems? Insights from Tumorspheres Derived from Primary Colon Cancer Tissue.
    PLoS One. 2016;11:e0146052.
    PubMed     Text format     Abstract available


  34. JIANG Z, Wang X, Tan X, Fan Z, et al
    Effect of Age on Survival Outcome in Operated and Non-Operated Patients with Colon Cancer: A Population-Based Study.
    PLoS One. 2016;11:e0147383.
    PubMed     Text format     Abstract available


  35. SEMLALI A, Reddy Parine N, Arafah M, Mansour L, et al
    Expression and Polymorphism of Toll-Like Receptor 4 and Effect on NF-kappaB Mediated Inflammation in Colon Cancer Patients.
    PLoS One. 2016;11:e0146333.
    PubMed     Text format     Abstract available


  36. SEEKHUNTOD S, Thavarungkul P, Chaichanawongsaroj N
    Validation of a Multiplex Allele-Specific Polymerase Chain Reaction Assay for Detection of KRAS Gene Mutations in Formalin-Fixed, Paraffin-Embedded Tissues from Colorectal Cancer Patients.
    PLoS One. 2016;11:e0147672.
    PubMed     Text format     Abstract available


  37. YANO S, Takehara K, Miwa S, Kishimoto H, et al
    Improved Resection and Outcome of Colon-Cancer Liver Metastasis with Fluorescence-Guided Surgery Using In Situ GFP Labeling with a Telomerase-Dependent Adenovirus in an Orthotopic Mouse Model.
    PLoS One. 2016;11:e0148760.
    PubMed     Text format     Abstract available


  38. GALAS A, Miszczyk J
    Aberrations Involving Chromosome 1 as a Possible Predictor of Odds Ratio for Colon Cancer - Results from the Krakow Case-Control Study.
    PLoS One. 2016;11:e0147658.
    PubMed     Text format     Abstract available


  39. FELDMAN M, Hershkovitz I, Sklan EH, Kahila Bar-Gal G, et al
    Detection of a Tumor Suppressor Gene Variant Predisposing to Colorectal Cancer in an 18th Century Hungarian Mummy.
    PLoS One. 2016;11:e0147217.
    PubMed     Text format     Abstract available


  40. YUEH AE, Payne SN, Leystra AA, Van De Hey DR, et al
    Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K.
    PLoS One. 2016;11:e0148730.
    PubMed     Text format     Abstract available


  41. PAHK K, Rhee S, Kim S, Choe JG, et al
    Predictive Role of Functional Visceral Fat Activity Assessed by Preoperative F-18 FDG PET/CT for Regional Lymph Node or Distant Metastasis in Patients with Colorectal Cancer.
    PLoS One. 2016;11:e0148776.
    PubMed     Text format     Abstract available


  42. LE ROY B, Tixier L, Pereira B, Sauvanet P, et al
    Assessment of the Relation between the Expression of Oxaliplatin Transporters in Colorectal Cancer and Response to FOLFOX-4 Adjuvant Chemotherapy: A Case Control Study.
    PLoS One. 2016;11:e0148739.
    PubMed     Text format     Abstract available


  43. DI CARO G, Carvello M, Pesce S, Erreni M, et al
    Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer.
    PLoS One. 2016;11:e0148186.
    PubMed     Text format     Abstract available


  44. GONG HX, Zhang KB, Wu LM, Baigorri BF, et al
    Dual Energy Spectral CT Imaging for Colorectal Cancer Grading: A Preliminary Study.
    PLoS One. 2016;11:e0147756.
    PubMed     Text format     Abstract available


  45. TENG JA, Wu SG, Chen JX, Li Q, et al
    The Activation of ERK1/2 and JNK MAPK Signaling by Insulin/IGF-1 Is Responsible for the Development of Colon Cancer with Type 2 Diabetes Mellitus.
    PLoS One. 2016;11:e0149822.
    PubMed     Text format     Abstract available


  46. CHADDAD A, Desrosiers C, Bouridane A, Toews M, et al
    Multi Texture Analysis of Colorectal Cancer Continuum Using Multispectral Imagery.
    PLoS One. 2016;11:e0149893.
    PubMed     Text format     Abstract available



  47. Correction: What Do We Learn from Spheroid Culture Systems? Insights from Tumorspheres Derived from Primary Colon Cancer Tissue.
    PLoS One. 2016;11:e0150179.
    PubMed     Text format     Abstract available


  48. FERNANDEZ-MARCELO T, Sanchez-Pernaute A, Pascua I, De Juan C, et al
    Clinical Relevance of Telomere Status and Telomerase Activity in Colorectal Cancer.
    PLoS One. 2016;11:e0149626.
    PubMed     Text format     Abstract available


  49. TROCHE JR, Mayne ST, Freedman ND, Shebl FM, et al
    Alcohol Consumption-Related Metabolites in Relation to Colorectal Cancer and Adenoma: Two Case-Control Studies Using Serum Biomarkers.
    PLoS One. 2016;11:e0150962.
    PubMed     Text format     Abstract available


  50. ERZINGER MM, Bovet C, Hecht KM, Senger S, et al
    Sulforaphane Preconditioning Sensitizes Human Colon Cancer Cells towards the Bioreductive Anticancer Prodrug PR-104A.
    PLoS One. 2016;11:e0150219.
    PubMed     Text format     Abstract available


  51. SETH C, Ruiz I Altaba A
    Metastases and Colon Cancer Tumor Growth Display Divergent Responses to Modulation of Canonical WNT Signaling.
    PLoS One. 2016;11:e0150697.
    PubMed     Text format     Abstract available


  52. ZHANG D, Fei Q, Li J, Zhang C, et al
    2-Deoxyglucose Reverses the Promoting Effect of Insulin on Colorectal Cancer Cells In Vitro.
    PLoS One. 2016;11:e0151115.
    PubMed     Text format     Abstract available


  53. WU X, He X, Li S, Xu X, et al
    Long Non-Coding RNA ucoo2kmd.1 Regulates CD44-Dependent Cell Growth by Competing for miR-211-3p in Colorectal Cancer.
    PLoS One. 2016;11:e0151287.
    PubMed     Text format     Abstract available


  54. SINHA R, Ahn J, Sampson JN, Shi J, et al
    Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations.
    PLoS One. 2016;11:e0152126.
    PubMed     Text format     Abstract available


  55. ZHOU Z, Zhang H, Lai J, Diao D, et al
    Relationships between p14ARF Gene Methylation and Clinicopathological Features of Colorectal Cancer: A Meta-Analysis.
    PLoS One. 2016;11:e0152050.
    PubMed     Text format     Abstract available


  56. WANG Y, Sun J, Ma C, Gao W, et al
    Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling Pathway.
    PLoS One. 2016;11:e0152599.
    PubMed     Text format     Abstract available


  57. LU YW, Zhang HF, Liang R, Xie ZR, et al
    Colorectal Cancer Genetic Heterogeneity Delineated by Multi-Region Sequencing.
    PLoS One. 2016;11:e0152673.
    PubMed     Text format     Abstract available


  58. WEIDNER C, Rousseau M, Plauth A, Wowro SJ, et al
    Iberis amara Extract Induces Intracellular Formation of Reactive Oxygen Species and Inhibits Colon Cancer.
    PLoS One. 2016;11:e0152398.
    PubMed     Text format     Abstract available


  59. LAI MC, Chang CM, Sun HS
    Hypoxia Induces Autophagy through Translational Up-Regulation of Lysosomal Proteins in Human Colon Cancer Cells.
    PLoS One. 2016;11:e0153627.
    PubMed     Text format     Abstract available


  60. LEONG KH, Looi CY, Loong XM, Cheah FK, et al
    Cycloart-24-ene-26-ol-3-one, a New Cycloartane Isolated from Leaves of Aglaia exima Triggers Tumour Necrosis Factor-Receptor 1-Mediated Caspase-Dependent Apoptosis in Colon Cancer Cell Line.
    PLoS One. 2016;11:e0152652.
    PubMed     Text format     Abstract available


  61. MULLANY LE, Herrick JS, Wolff RK, Slattery ML, et al
    MicroRNA Seed Region Length Impact on Target Messenger RNA Expression and Survival in Colorectal Cancer.
    PLoS One. 2016;11:e0154177.
    PubMed     Text format     Abstract available


  62. SIEGELMANN-DANIELI N, Farkash A, Katzir I, Vesterman Landes J, et al
    A Novel Computational Tool for Mining Real-Life Data: Application in the Metastatic Colorectal Cancer Care Setting.
    PLoS One. 2016;11:e0154689.
    PubMed     Text format     Abstract available


  63. ZHU L, Dong C, Cao Y, Fang X, et al
    Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials.
    PLoS One. 2016;11:e0154795.
    PubMed     Text format     Abstract available


  64. ARELAKI S, Arampatzioglou A, Kambas K, Papagoras C, et al
    Gradient Infiltration of Neutrophil Extracellular Traps in Colon Cancer and Evidence for Their Involvement in Tumour Growth.
    PLoS One. 2016;11:e0154484.
    PubMed     Text format     Abstract available


  65. ZEKRI AR, Youssef AS, Lotfy MM, Gabr R, et al
    Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.
    PLoS One. 2016;11:e0154130.
    PubMed     Text format     Abstract available


  66. CHEN X, Deane NG, Lewis KB, Li J, et al
    Comparison of Nanostring nCounter(R) Data on FFPE Colon Cancer Samples and Affymetrix Microarray Data on Matched Frozen Tissues.
    PLoS One. 2016;11:e0153784.
    PubMed     Text format     Abstract available


  67. HUO H, Zhou Z, Qin J, Liu W, et al
    Erastin Disrupts Mitochondrial Permeability Transition Pore (mPTP) and Induces Apoptotic Death of Colorectal Cancer Cells.
    PLoS One. 2016;11:e0154605.
    PubMed     Text format     Abstract available


  68. VOGTMANN E, Hua X, Zeller G, Sunagawa S, et al
    Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing.
    PLoS One. 2016;11:e0155362.
    PubMed     Text format     Abstract available


  69. CHOU CK, Chen SL, Yen AM, Chiu SY, et al
    Outreach and Inreach Organized Service Screening Programs for Colorectal Cancer.
    PLoS One. 2016;11:e0155276.
    PubMed     Text format     Abstract available


  70. FOSTER C, Haviland J, Winter J, Grimmett C, et al
    Pre-Surgery Depression and Confidence to Manage Problems Predict Recovery Trajectories of Health and Wellbeing in the First Two Years following Colorectal Cancer: Results from the CREW Cohort Study.
    PLoS One. 2016;11:e0155434.
    PubMed     Text format     Abstract available


  71. BUHL IK, Gerster S, Delorenzi M, Jensen T, et al
    Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial Data.
    PLoS One. 2016;11:e0155123.
    PubMed     Text format     Abstract available


  72. LI B, Gan A, Chen X, Wang X, et al
    Diagnostic Performance of DNA Hypermethylation Markers in Peripheral Blood for the Detection of Colorectal Cancer: A Meta-Analysis and Systematic Review.
    PLoS One. 2016;11:e0155095.
    PubMed     Text format     Abstract available


  73. KIM JC, Ha YJ, Tak KH, Roh SA, et al
    Complex Behavior of ALDH1A1 and IGFBP1 in Liver Metastasis from a Colorectal Cancer.
    PLoS One. 2016;11:e0155160.
    PubMed     Text format     Abstract available


  74. AAN DE STEGGE WB, van Leeuwen BL, Elferink MA, de Bock GH, et al
    The Evaluation of More Lymph Nodes in Colon Cancer Is Associated with Improved Survival in Patients of All Ages.
    PLoS One. 2016;11:e0155608.
    PubMed     Text format     Abstract available


  75. VAN HELDEN EJ, Hoekstra OS, Boellaard R, Roth C, et al
    Early 18F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.
    PLoS One. 2016;11:e0155178.
    PubMed     Text format     Abstract available


  76. GORGES TM, Stein A, Quidde J, Hauch S, et al
    Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch(R) System and the AdnaTest(R).
    PLoS One. 2016;11:e0155126.
    PubMed     Text format     Abstract available


  77. DI CARO G, Carvello M, Pesce S, Erreni M, et al
    Correction: Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer.
    PLoS One. 2016;11:e0156669.
    PubMed     Text format     Abstract available


  78. HUSSAIN T, Chang HY, Luu NP, Pollack CE, et al
    The Value of Continuity between Primary Care and Surgical Care in Colon Cancer.
    PLoS One. 2016;11:e0155789.
    PubMed     Text format     Abstract available


  79. ADAMS SV, Ceballos R, Newcomb PA
    Quality of Life and Mortality of Long-Term Colorectal Cancer Survivors in the Seattle Colorectal Cancer Family Registry.
    PLoS One. 2016;11:e0156534.
    PubMed     Text format     Abstract available


  80. PALANIAPPAN A, Ramar K, Ramalingam S
    Computational Identification of Novel Stage-Specific Biomarkers in Colorectal Cancer Progression.
    PLoS One. 2016;11:e0156665.
    PubMed     Text format     Abstract available


  81. EYKING A, Reis H, Frank M, Gerken G, et al
    MiR-205 and MiR-373 Are Associated with Aggressive Human Mucinous Colorectal Cancer.
    PLoS One. 2016;11:e0156871.
    PubMed     Text format     Abstract available


  82. HAMIDOU Z, Chibaudel B, Hebbar M, Hug de Larauze M, et al
    Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial.
    PLoS One. 2016;11:e0157067.
    PubMed     Text format     Abstract available


  83. ALKHAYAL KA, Awadalia ZH, Vaali-Mohammed MA, Al Obeed OA, et al
    Association of Vitamin D Receptor Gene Polymorphisms with Colorectal Cancer in a Saudi Arabian Population.
    PLoS One. 2016;11:e0155236.
    PubMed     Text format     Abstract available


  84. VELUCHAMY JP, Spanholtz J, Tordoir M, Thijssen VL, et al
    Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer.
    PLoS One. 2016;11:e0157830.
    PubMed     Text format     Abstract available


  85. HU S, Zou Z, Li H, Zou G, et al
    The Preoperative Peripheral Blood Monocyte Count Is Associated with Liver Metastasis and Overall Survival in Colorectal Cancer Patients.
    PLoS One. 2016;11:e0157486.
    PubMed     Text format     Abstract available


  86. LIN PC, Yang YF, Tyan YC, Hsiao ES, et al
    Identification of Phosphorylated Cyclin-Dependent Kinase 1 Associated with Colorectal Cancer Survival Using Label-Free Quantitative Analyses.
    PLoS One. 2016;11:e0158844.
    PubMed     Text format     Abstract available


  87. NEGM OH, Hamed MR, Schoen RE, Whelan RL, et al
    Human Blood Autoantibodies in the Detection of Colorectal Cancer.
    PLoS One. 2016;11:e0156971.
    PubMed     Text format     Abstract available


  88. GOGOI P, Sepehri S, Zhou Y, Gorin MA, et al
    Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood Samples.
    PLoS One. 2016;11:e0147400.
    PubMed     Text format     Abstract available


  89. NOVESKI P, Madjunkova S, Sukarova Stefanovska E, Matevska Geshkovska N, et al
    Loss of Y Chromosome in Peripheral Blood of Colorectal and Prostate Cancer Patients.
    PLoS One. 2016;11:e0146264.
    PubMed     Text format     Abstract available


  90. SATO KA, Hachiya T, Iwaya T, Kume K, et al
    Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel.
    PLoS One. 2016;11:e0146275.
    PubMed     Text format     Abstract available


  91. TIPTIRI-KOURPETI A, Spyridopoulou K, Santarmaki V, Aindelis G, et al
    Lactobacillus casei Exerts Anti-Proliferative Effects Accompanied by Apoptotic Cell Death and Up-Regulation of TRAIL in Colon Carcinoma Cells.
    PLoS One. 2016;11:e0147960.
    PubMed     Text format     Abstract available


  92. FEIERSINGER F, Nolte E, Wach S, Rau TT, et al
    MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal Carcinoma.
    PLoS One. 2016;11:e0148580.
    PubMed     Text format     Abstract available


  93. MAIDEN SL, Petrova YI, Gumbiner BM
    Microtubules Inhibit E-Cadherin Adhesive Activity by Maintaining Phosphorylated p120-Catenin in a Colon Carcinoma Cell Model.
    PLoS One. 2016;11:e0148574.
    PubMed     Text format     Abstract available


  94. LEE LS, Seng KY, Wang LZ, Yong WP, et al
    Phenotyping of UGT1A1 Activity Using Raltegravir Predicts Pharmacokinetics and Toxicity of Irinotecan in FOLFIRI.
    PLoS One. 2016;11:e0147681.
    PubMed     Text format     Abstract available


  95. CEA SORIANO L, Soriano-Gabarro M, Garcia Rodriguez LA
    The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical Practice.
    PLoS One. 2016;11:e0159179.
    PubMed     Text format     Abstract available


  96. TAKAYA A, Hirohashi Y, Murai A, Morita R, et al
    Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480.
    PLoS One. 2016;11:e0158903.
    PubMed     Text format     Abstract available


  97. PHANG CW, Karsani SA, Sethi G, Abd Malek SN, et al
    Flavokawain C Inhibits Cell Cycle and Promotes Apoptosis, Associated with Endoplasmic Reticulum Stress and Regulation of MAPKs and Akt Signaling Pathways in HCT 116 Human Colon Carcinoma Cells.
    PLoS One. 2016;11:e0148775.
    PubMed     Text format     Abstract available


  98. REYES-ZURITA FJ, Rufino-Palomares EE, Garcia-Salguero L, Peragon J, et al
    Maslinic Acid, a Natural Triterpene, Induces a Death Receptor-Mediated Apoptotic Mechanism in Caco-2 p53-Deficient Colon Adenocarcinoma Cells.
    PLoS One. 2016;11:e0146178.
    PubMed     Text format     Abstract available


  99. JIMENEZ S, Gascon S, Luquin A, Laguna M, et al
    Rosa canina Extracts Have Antiproliferative and Antioxidant Effects on Caco-2 Human Colon Cancer.
    PLoS One. 2016;11:e0159136.
    PubMed     Text format     Abstract available


  100. ZHOU J, Chang L, Guan Y, Yang L, et al
    Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer.
    PLoS One. 2016;11:e0159708.
    PubMed     Text format     Abstract available


  101. KIM SH, Park YY, Cho SN, Margalit O, et al
    Kruppel-Like Factor 12 Promotes Colorectal Cancer Growth through Early Growth Response Protein 1.
    PLoS One. 2016;11:e0159899.
    PubMed     Text format     Abstract available


  102. GRANDE R, Natoli C, Ciancola F, Gemma D, et al
    Treatment of Metastatic Colorectal Cancer Patients >/=75 Years Old in Clinical Practice: A Multicenter Analysis.
    PLoS One. 2016;11:e0157751.
    PubMed     Text format     Abstract available


  103. COSTA-CABRAL S, Brough R, Konde A, Aarts M, et al
    CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
    PLoS One. 2016;11:e0149099.
    PubMed     Text format     Abstract available


  104. KUAN CS, See Too WC, Few LL
    Sp1 and Sp3 Are the Transcription Activators of Human ek1 Promoter in TSA-Treated Human Colon Carcinoma Cells.
    PLoS One. 2016;11:e0147886.
    PubMed     Text format     Abstract available


  105. SETH C, Ruiz I Altaba A
    Correction: Metastases and Colon Cancer Tumor Growth Display Divergent Responses to Modulation of Canonical WNT Signaling.
    PLoS One. 2016;11:e0160904.
    PubMed     Text format     Abstract available


  106. CHEN W, Li Q, Fan Y, Li D, et al
    Factors Predicting Difficulty of Laparoscopic Low Anterior Resection for Rectal Cancer with Total Mesorectal Excision and Double Stapling Technique.
    PLoS One. 2016;11:e0151773.
    PubMed     Text format     Abstract available


  107. NAM SK, Yun S, Koh J, Kwak Y, et al
    BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.
    PLoS One. 2016;11:e0151865.
    PubMed     Text format     Abstract available


  108. ERIKSEN AH, Andersen RF, Pallisgaard N, Sorensen FB, et al
    MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer.
    PLoS One. 2016;11:e0150593.
    PubMed     Text format     Abstract available


  109. MARTINO-ECHARRI E, Brocardo MG, Mills KM, Henderson BR, et al
    Tankyrase Inhibitors Stimulate the Ability of Tankyrases to Bind Axin and Drive Assembly of beta-Catenin Degradation-Competent Axin Puncta.
    PLoS One. 2016;11:e0150484.
    PubMed     Text format     Abstract available


  110. PINTO AT, Pinto ML, Velho S, Pinto MT, et al
    Intricate Macrophage-Colorectal Cancer Cell Communication in Response to Radiation.
    PLoS One. 2016;11:e0160891.
    PubMed     Text format     Abstract available


  111. CHANG YJ, Cheng YW, Lin RK, Huang CC, et al
    Thrombomodulin Influences the Survival of Patients with Non-Metastatic Colorectal Cancer through Epithelial-To-Mesenchymal Transition (EMT).
    PLoS One. 2016;11:e0160550.
    PubMed     Text format     Abstract available


  112. KANG MR, Park KH, Yang JO, Lee CW, et al
    miR-6734 Up-Regulates p21 Gene Expression and Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Cells.
    PLoS One. 2016;11:e0160961.
    PubMed     Text format     Abstract available


  113. JI K, Zhang M, Chu Q, Gan Y, et al
    The Role of p-STAT3 as a Prognostic and Clinicopathological Marker in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0160125.
    PubMed     Text format     Abstract available


  114. NANDA N, Dhawan DK, Bhatia A, Mahmood A, et al
    Doxycycline Promotes Carcinogenesis & Metastasis via Chronic Inflammatory Pathway: An In Vivo Approach.
    PLoS One. 2016;11:e0151539.
    PubMed     Text format     Abstract available


  115. CHEN JY, Tsai WS, Shao HJ, Wu JC, et al
    Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection.
    PLoS One. 2016;11:e0149633.
    PubMed     Text format     Abstract available


  116. ZHANG J, Yi M, Zha L, Chen S, et al
    Sodium Butyrate Induces Endoplasmic Reticulum Stress and Autophagy in Colorectal Cells: Implications for Apoptosis.
    PLoS One. 2016;11:e0147218.
    PubMed     Text format     Abstract available


  117. KIM H, Myoung S, Koom WS, Kim NK, et al
    MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection.
    PLoS One. 2016;11:e0146235.
    PubMed     Text format     Abstract available


  118. YAN H, Hu K, Wu W, Li Y, et al
    Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
    PLoS One. 2016;11:e0159954.
    PubMed     Text format     Abstract available


  119. SONG LP, Wang HY
    Modeling and Control of Colorectal Cancer.
    PLoS One. 2016;11:e0161349.
    PubMed     Text format     Abstract available


  120. JO P, Konig A, Schirmer M, Kitz J, et al
    Heterogeneity of KRAS Mutation Status in Rectal Cancer.
    PLoS One. 2016;11:e0153278.
    PubMed     Text format     Abstract available


  121. OKERBERG ES, Hainley A, Brown H, Aban A, et al
    Identification of a Tumor Specific, Active-Site Mutation in Casein Kinase 1alpha by Chemical Proteomics.
    PLoS One. 2016;11:e0152934.
    PubMed     Text format     Abstract available


  122. BAJENOVA O, Gorbunova A, Evsyukov I, Rayko M, et al
    The Genome-Wide Analysis of Carcinoembryonic Antigen Signaling by Colorectal Cancer Cells Using RNA Sequencing.
    PLoS One. 2016;11:e0161256.
    PubMed     Text format     Abstract available


  123. ILIC I, Jankovic S, Ilic M
    Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis.
    PLoS One. 2016;11:e0161912.
    PubMed     Text format     Abstract available


  124. CHEN YG, Chen MQ, Guo YY, Li SC, et al
    Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
    PLoS One. 2016;11:e0153944.
    PubMed     Text format     Abstract available


  125. SUNDSTROM A, Grabocka E, Bar-Sagi D, Mishra B, et al
    Histological Image Processing Features Induce a Quantitative Characterization of Chronic Tumor Hypoxia.
    PLoS One. 2016;11:e0153623.
    PubMed     Text format     Abstract available


  126. ABULI A, Castells A, Bujanda L, Lozano JJ, et al
    Genetic Variants Associated with Colorectal Adenoma Susceptibility.
    PLoS One. 2016;11:e0153084.
    PubMed     Text format     Abstract available


  127. ISSOP L, Ostuni MA, Lee S, Laforge M, et al
    Translocator Protein-Mediated Stabilization of Mitochondrial Architecture during Inflammation Stress in Colonic Cells.
    PLoS One. 2016;11:e0152919.
    PubMed     Text format     Abstract available


  128. MILLER CL, Muthupalani S, Shen Z, Drees F, et al
    Lamellipodin-Deficient Mice: A Model of Rectal Carcinoma.
    PLoS One. 2016;11:e0152940.
    PubMed     Text format     Abstract available


  129. HASEGAWA K, Saiura A, Takayama T, Miyagawa S, et al
    Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial.
    PLoS One. 2016;11:e0162400.
    PubMed     Text format     Abstract available


  130. FALCONE E, Grandoni L, Garibaldi F, Manni I, et al
    Infinity: An In-Silico Tool for Genome-Wide Prediction of Specific DNA Matrices in miRNA Genomic Loci.
    PLoS One. 2016;11:e0153658.
    PubMed     Text format     Abstract available


  131. CATALAN V, Gomez-Ambrosi J, Rodriguez A, Ramirez B, et al
    Increased Obesity-Associated Circulating Levels of the Extracellular Matrix Proteins Osteopontin, Chitinase-3 Like-1 and Tenascin C Are Associated with Colon Cancer.
    PLoS One. 2016;11:e0162189.
    PubMed     Text format     Abstract available


  132. CHEN J, Raju GS, Jogunoori W, Menon V, et al
    Mutational Profiles Reveal an Aberrant TGF-beta-CEA Regulated Pathway in Colon Adenomas.
    PLoS One. 2016;11:e0153933.
    PubMed     Text format     Abstract available


  133. GU X, Gao XS, Qin S, Li X, et al
    Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer.
    PLoS One. 2016;11:e0163523.
    PubMed     Text format     Abstract available


  134. BOTTICELLI A, Borro M, Onesti CE, Strigari L, et al
    Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker?
    PLoS One. 2016;11:e0163105.
    PubMed     Text format     Abstract available


  135. TSUKIHARA H, Tsunekuni K, Takechi T
    Folic Acid-Metabolizing Enzymes Regulate the Antitumor Effect of 5-Fluoro-2'-Deoxyuridine in Colorectal Cancer Cell Lines.
    PLoS One. 2016;11:e0163961.
    PubMed     Text format     Abstract available


  136. NIRVANAPPA AC, Mohan CD, Rangappa S, Ananda H, et al
    Novel Synthetic Oxazines Target NF-kappaB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.
    PLoS One. 2016;11:e0163209.
    PubMed     Text format     Abstract available


  137. SOLASSOL J, Vendrell J, Markl B, Haas C, et al
    Multi-Center Evaluation of the Fully Automated PCR-Based Idylla KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.
    PLoS One. 2016;11:e0163444.
    PubMed     Text format     Abstract available


  138. HUANG WS, Hsieh MC, Huang CY, Kuo YH, et al
    The Association of CXC Receptor 4 Mediated Signaling Pathway with Oxaliplatin-Resistant Human Colorectal Cancer Cells.
    PLoS One. 2016;11:e0159927.
    PubMed     Text format     Abstract available


  139. CHANG YT, Huang MY, Yeh YS, Huang CW, et al
    A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer.
    PLoS One. 2016;11:e0163264.
    PubMed     Text format     Abstract available


  140. BUDHATHOKI S, Yamaji T, Iwasaki M, Sawada N, et al
    Vitamin D Receptor Gene Polymorphism and the Risk of Colorectal Cancer: A Nested Case-Control Study.
    PLoS One. 2016;11:e0164648.
    PubMed     Text format     Abstract available


  141. COMAS M, Mendivil J, Andreu M, Hernandez C, et al
    Long-Term Prediction of the Demand of Colonoscopies Generated by a Population-Based Colorectal Cancer Screening Program.
    PLoS One. 2016;11:e0164666.
    PubMed     Text format     Abstract available


  142. SUN X, Hu Y, Zhang L, Hu C, et al
    Mining, Validation, and Clinical Significance of Colorectal Cancer (CRC)-Associated lncRNAs.
    PLoS One. 2016;11:e0164590.
    PubMed     Text format     Abstract available


  143. LOPE V, Fernandez de Larrea N, Perez-Gomez B, Martin V, et al
    Menstrual and Reproductive Factors and Risk of Gastric and Colorectal Cancer in Spain.
    PLoS One. 2016;11:e0164620.
    PubMed     Text format     Abstract available


  144. LIN J, Hiraoka K, Watanabe T, Kuo T, et al
    Identification of Binding Targets of a Pyrrole-Imidazole Polyamide KR12 in the LS180 Colorectal Cancer Genome.
    PLoS One. 2016;11:e0165581.
    PubMed     Text format     Abstract available


  145. IGUCHI T, Nambara S, Masuda T, Komatsu H, et al
    miR-146a Polymorphism (rs2910164) Predicts Colorectal Cancer Patients' Susceptibility to Liver Metastasis.
    PLoS One. 2016;11:e0165912.
    PubMed     Text format     Abstract available


  146. LENNARD KS, Goosen RW, Blackburn JM
    Bacterially-Associated Transcriptional Remodelling in a Distinct Genomic Subtype of Colorectal Cancer Provides a Plausible Molecular Basis for Disease Development.
    PLoS One. 2016;11:e0166282.
    PubMed     Text format     Abstract available


  147. MIGUCHI M, Hinoi T, Shimomura M, Adachi T, et al
    Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor beta Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
    PLoS One. 2016;11:e0166422.
    PubMed     Text format     Abstract available


  148. KAMIZA AB, Hsieh LL, Tang R, Chien HT, et al
    TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study.
    PLoS One. 2016;11:e0167354.
    PubMed     Text format     Abstract available


  149. YAP R, Wilkins S, Staples M, Oliva K, et al
    The Effect of Diabetes on the Perioperative Outcomes of Colorectal Cancer Surgery Patients.
    PLoS One. 2016;11:e0167271.
    PubMed     Text format     Abstract available


  150. CHANDLER PD, Akinkuolie AO, Tobias DK, Lawler PR, et al
    Association of N-Linked Glycoprotein Acetyls and Colorectal Cancer Incidence and Mortality.
    PLoS One. 2016;11:e0165615.
    PubMed     Text format     Abstract available


  151. ALAJEZ NM
    Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant Recurrence.
    PLoS One. 2016;11:e0167455.
    PubMed     Text format     Abstract available


  152. TOMINAGA T, Nonaka T, Sumida Y, Hidaka S, et al
    The C-Reactive Protein to Albumin Ratio as a Predictor of Severe Side Effects of Adjuvant Chemotherapy in Stage III Colorectal Cancer Patients.
    PLoS One. 2016;11:e0167967.
    PubMed     Text format     Abstract available


  153. KAI M, Niinuma T, Kitajima H, Yamamoto E, et al
    TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells.
    PLoS One. 2016;11:e0168281.
    PubMed     Text format     Abstract available


  154. RAMAKER K, Bade S, Rockendorf N, Meckelein B, et al
    Absence of the Epithelial Glycocalyx As Potential Tumor Marker for the Early Detection of Colorectal Cancer.
    PLoS One. 2016;11:e0168801.
    PubMed     Text format     Abstract available


  155. ZHANG ZY, Li C, Gao W, Yin XW, et al
    A Nomogram to Predict Adequate Lymph Node Recovery before Resection of Colorectal Cancer.
    PLoS One. 2016;11:e0168156.
    PubMed     Text format     Abstract available


  156. VARGAS T, Moreno-Rubio J, Herranz J, Cejas P, et al
    3'UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer Patients.
    PLoS One. 2016;11:e0168423.
    PubMed     Text format     Abstract available


  157. MULLINS CS, Huhns M, Krohn M, Peters S, et al
    Generation, Characterization and Application of Antibodies Directed against HERV-H Gag Protein in Colorectal Samples.
    PLoS One. 2016;11:e0153349.
    PubMed     Text format     Abstract available


  158. WANG X, Ji P, Zhang Y, LaComb JF, et al
    Aberrant DNA Methylation: Implications in Racial Health Disparity.
    PLoS One. 2016;11:e0153125.
    PubMed     Text format     Abstract available


    January 2015
  159. WATT DG, Proctor MJ, Park JH, Horgan PG, et al
    The Neutrophil-Platelet Score (NPS) Predicts Survival in Primary Operable Colorectal Cancer and a Variety of Common Cancers.
    PLoS One. 2015;10:e0142159.
    PubMed     Text format     Abstract available


  160. ABDEL HADI L, Di Vito C, Marfia G, Ferraretto A, et al
    Sphingosine Kinase 2 and Ceramide Transport as Key Targets of the Natural Flavonoid Luteolin to Induce Apoptosis in Colon Cancer Cells.
    PLoS One. 2015;10:e0143384.
    PubMed     Text format     Abstract available


  161. SHIN A, Lee J, Lee J, Park MS, et al
    Isoflavone and Soyfood Intake and Colorectal Cancer Risk: A Case-Control Study in Korea.
    PLoS One. 2015;10:e0143228.
    PubMed     Text format     Abstract available


  162. YONESAKA K, Takegawa N, Satoh T, Ueda H, et al
    Combined Analysis of Plasma Amphiregulin and Heregulin Predicts Response to Cetuximab in Metastatic Colorectal Cancer.
    PLoS One. 2015;10:e0143132.
    PubMed     Text format     Abstract available


  163. GRANATA V, Fusco R, Catalano O, Filice S, et al
    Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging.
    PLoS One. 2015;10:e0142876.
    PubMed     Text format     Abstract available


  164. VECE MM, Agnoli C, Grioni S, Sieri S, et al
    Dietary Total Antioxidant Capacity and Colorectal Cancer in the Italian EPIC Cohort.
    PLoS One. 2015;10:e0142995.
    PubMed     Text format     Abstract available


  165. WAGHELA BN, Sharma A, Dhumale S, Pandey SM, et al
    Curcumin conjugated with PLGA potentiates sustainability, anti-proliferative activity and apoptosis in human colon carcinoma cells.
    PLoS One. 2015;10:e0117526.
    PubMed     Text format     Abstract available


  166. AHN SB, Chan C, Dent OF, Mohamedali A, et al
    Epithelial and stromal cell urokinase plasminogen activator receptor expression differentially correlates with survival in rectal cancer stages B and C patients.
    PLoS One. 2015;10:e0117786.
    PubMed     Text format     Abstract available


  167. ITO F, Ku AW, Bucsek MJ, Muhitch JB, et al
    Immune Adjuvant Activity of Pre-Resectional Radiofrequency Ablation Protects against Local and Systemic Recurrence in Aggressive Murine Colorectal Cancer.
    PLoS One. 2015;10:e0143370.
    PubMed     Text format     Abstract available


  168. SU S, Hong F, Liang Y, Zhou J, et al
    Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal Cancer.
    PLoS One. 2015;10:e0143513.
    PubMed     Text format     Abstract available


  169. JEONG YK, Kim MS, Lee JY, Kim EH, et al
    Metformin Radiosensitizes p53-Deficient Colorectal Cancer Cells through Induction of G2/M Arrest and Inhibition of DNA Repair Proteins.
    PLoS One. 2015;10:e0143596.
    PubMed     Text format     Abstract available


  170. MULLANY LE, Wolff RK, Herrick JS, Buas MF, et al
    SNP Regulation of microRNA Expression and Subsequent Colon Cancer Risk.
    PLoS One. 2015;10:e0143894.
    PubMed     Text format     Abstract available


  171. WENG MT, Tsao PN, Lin HL, Tung CC, et al
    Hes1 Increases the Invasion Ability of Colorectal Cancer Cells via the STAT3-MMP14 Pathway.
    PLoS One. 2015;10:e0144322.
    PubMed     Text format     Abstract available


  172. LINHARES MM, Affonso RJ Jr, Viana LS, Silva SR, et al
    Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival.
    PLoS One. 2015;10:e0144333.
    PubMed     Text format     Abstract available


  173. LIM Y, Han SW, Yoon JH, Lee JM, et al
    Clinical Implication of Anti-Angiogenic Effect of Regorafenib in Metastatic Colorectal Cancer.
    PLoS One. 2015;10:e0145004.
    PubMed     Text format     Abstract available


  174. MCCLELLAND D, Murray GI
    A Comprehensive Study of Extramural Venous Invasion in Colorectal Cancer.
    PLoS One. 2015;10:e0144987.
    PubMed     Text format     Abstract available


  175. WANG H, Iwasaki M, Haiman CA, Kono S, et al
    Interaction between Red Meat Intake and NAT2 Genotype in Increasing the Risk of Colorectal Cancer in Japanese and African Americans.
    PLoS One. 2015;10:e0144955.
    PubMed     Text format     Abstract available


  176. CHEN J, Xia Q, Jiang B, Chang W, et al
    Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    PLoS One. 2015;10:e0145164.
    PubMed     Text format     Abstract available


  177. BRIFFA R, Um I, Faratian D, Zhou Y, et al
    Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel Biomarkers.
    PLoS One. 2015;10:e0144708.
    PubMed     Text format     Abstract available


  178. LI J, Liang H, Bai M, Ning T, et al
    Correction: miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.
    PLoS One. 2015;10:e0145589.
    PubMed     Text format     Abstract available


  179. HANG J, Cai B, Xue P, Wang L, et al
    The Joint Effects of Lifestyle Factors and Comorbidities on the Risk of Colorectal Cancer: A Large Chinese Retrospective Case-Control Study.
    PLoS One. 2015;10:e0143696.
    PubMed     Text format     Abstract available


  180. PAN T, Sun J, Hu J, Hu Y, et al
    Correction: Cytohesins/ARNO: The Function in Colorectal Cancer Cells.
    PLoS One. 2015;10:e0146204.
    PubMed     Text format     Abstract available


  181. BOLTON L, Reiman A, Lucas K, Timms J, et al
    KRAS mutation analysis by PCR: a comparison of two methods.
    PLoS One. 2015;10:e0115672.
    PubMed     Text format     Abstract available


  182. LING C, Wang L, Wang Z, Xu L, et al
    A pathway-centric survey of somatic mutations in Chinese patients with colorectal carcinomas.
    PLoS One. 2015;10:e0116753.
    PubMed     Text format     Abstract available


  183. PUCCETTI P, Fallarino F, Italiano A, Soubeyran I, et al
    Accumulation of an endogenous tryptophan-derived metabolite in colorectal and breast cancers.
    PLoS One. 2015;10:e0122046.
    PubMed     Text format     Abstract available


  184. KIM Y, Bae JM, Li G, Cho NY, et al
    Image analyzer-based assessment of tumor-infiltrating T cell subsets and their prognostic values in colorectal carcinomas.
    PLoS One. 2015;10:e0122183.
    PubMed     Text format     Abstract available


  185. SENETTA R, Duregon E, Sonetto C, Spadi R, et al
    YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study.
    PLoS One. 2015;10:e0123759.
    PubMed     Text format     Abstract available


  186. CAO H, He N, Song S, Xu M, et al
    Is surveillance colonoscopy necessary for patients with sporadic gastric hyperplastic polyps?
    PLoS One. 2015;10:e0122996.
    PubMed     Text format     Abstract available


  187. ESCHBACH RS, Fendler WP, Kazmierczak PM, Hacker M, et al
    Correlation of Perfusion MRI and 18F-FDG PET Imaging Biomarkers for Monitoring Regorafenib Therapy in Experimental Colon Carcinomas with Immunohistochemical Validation.
    PLoS One. 2015;10:e0115543.
    PubMed     Text format     Abstract available


  188. SONG C, Song S, Kim JS, Oh HK, et al
    Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched Analysis.
    PLoS One. 2015;10:e0123657.
    PubMed     Text format     Abstract available


  189. VAQUE JP, Martinez N, Varela I, Fernandez F, et al
    Colorectal adenomas contain multiple somatic mutations that do not coincide with synchronous adenocarcinoma specimens.
    PLoS One. 2015;10:e0119946.
    PubMed     Text format     Abstract available


  190. LEE JH, Hwang I, Kang YN, Choi IJ, et al
    Genetic characteristics of mitochondrial DNA was associated with colorectal carcinogenesis and its prognosis.
    PLoS One. 2015;10:e0118612.
    PubMed     Text format     Abstract available


  191. DUPRE A, Melodelima D, Perol D, Chen Y, et al
    First clinical experience of intra-operative high intensity focused ultrasound in patients with colorectal liver metastases: a phase I-IIa study.
    PLoS One. 2015;10:e0118212.
    PubMed     Text format     Abstract available


  192. JUN E, Kim S, Kim JH, Cha K, et al
    Design of a multicomponent peptide-woven nanocomplex for delivery of siRNA.
    PLoS One. 2015;10:e0118310.
    PubMed     Text format     Abstract available


  193. LU NN, Jin J, Wang SL, Wang WH, et al
    Postoperative Capecitabine with Concurrent Intensity-Modulated Radiotherapy or Three-Dimensional Conformal Radiotherapy for Patients with Stage II and III Rectal Cancer.
    PLoS One. 2015;10:e0124601.
    PubMed     Text format     Abstract available


  194. HIRATSUKA M, Yamashita H, Akai F, Hosono H, et al
    Genetic polymorphisms of dihydropyrimidinase in a Japanese patient with capecitabine-induced toxicity.
    PLoS One. 2015;10:e0124818.
    PubMed     Text format     Abstract available


  195. GOUNARIS E, Heiferman MJ, Heiferman JR, Shrivastav M, et al
    Zileuton, 5-lipoxygenase inhibitor, acts as a chemopreventive agent in intestinal polyposis, by modulating polyp and systemic inflammation.
    PLoS One. 2015;10:e0121402.
    PubMed     Text format     Abstract available


  196. YING Q, Ansong E, Diamond AM, Lu Z, et al
    Quantitative proteomic analysis reveals that anti-cancer effects of selenium-binding protein 1 in vivo are associated with metabolic pathways.
    PLoS One. 2015;10:e0126285.
    PubMed     Text format     Abstract available


  197. ZHANG Y, Zhao PW, Feng G, Xie G, et al
    The expression level and prognostic value of Y-box binding protein-1 in rectal cancer.
    PLoS One. 2015;10:e0119385.
    PubMed     Text format     Abstract available


  198. SERA F, Ferrari P
    A multilevel model to estimate the within- and the between-center components of the exposure/disease association in the EPIC study.
    PLoS One. 2015;10:e0117815.
    PubMed     Text format     Abstract available


  199. SUNDARAMOORTHY P, Sim JJ, Jang YS, Mishra SK, et al
    Modulation of intracellular calcium levels by calcium lactate affects colon cancer cell motility through calcium-dependent calpain.
    PLoS One. 2015;10:e0116984.
    PubMed     Text format     Abstract available


  200. WANG QX, Li SH, Zhang X, Xie L, et al
    Identification of locally advanced rectal cancer with low risk of local recurrence.
    PLoS One. 2015;10:e0117141.
    PubMed     Text format     Abstract available


  201. ZHANG J, Jiang K, Lv L, Wang H, et al
    Use of genome-wide association studies for cancer research and drug repositioning.
    PLoS One. 2015;10:e0116477.
    PubMed     Text format     Abstract available


  202. ANDERSEN V, Vogel LK, Kopp TI, Saebo M, et al
    High ABCC2 and low ABCG2 gene expression are early events in the colorectal adenoma-carcinoma sequence.
    PLoS One. 2015;10:e0119255.
    PubMed     Text format     Abstract available


  203. ZENG Y, Liu Y, Shang J, Ma J, et al
    Phosphorescence monitoring of hypoxic microenvironment in solid-tumors to evaluate chemotherapeutic effects using the hypoxia-sensitive iridium (III) coordination compound.
    PLoS One. 2015;10:e0121293.
    PubMed     Text format     Abstract available


  204. SINGH S, Arcaroli J, Chen Y, Thompson DC, et al
    ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/beta-Catenin, Notch and PI3K/Akt Signaling Pathways.
    PLoS One. 2015;10:e0121648.
    PubMed     Text format     Abstract available


  205. KUAN JC, Wu CC, Sun CA, Chu CM, et al
    DNA methylation combinations in adjacent normal colon tissue predict cancer recurrence: evidence from a clinical cohort study.
    PLoS One. 2015;10:e0123396.
    PubMed     Text format     Abstract available


  206. WU X, Xu X, Li S, Wu S, et al
    Identification and validation of potential biomarkers for the detection of dysregulated microRNA by qPCR in patients with colorectal adenocarcinoma.
    PLoS One. 2015;10:e0120024.
    PubMed     Text format     Abstract available


  207. YE J, Jiang L, Wu C, Liu A, et al
    Three ADIPOR1 Polymorphisms and Cancer Risk: A Meta-Analysis of Case-Control Studies.
    PLoS One. 2015;10:e0127253.
    PubMed     Text format     Abstract available


  208. LIN CM, Huang HL, Chu FY, Fan HC, et al
    Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study.
    PLoS One. 2015;10:e0125421.
    PubMed     Text format     Abstract available


  209. STAFFA L, Echterdiek F, Nelius N, Benner A, et al
    Mismatch repair-deficient crypt foci in Lynch syndrome--molecular alterations and association with clinical parameters.
    PLoS One. 2015;10:e0121980.
    PubMed     Text format     Abstract available


  210. PATTERSON SD, Rossi JM, Paweletz KL, Fitzpatrick VD, et al
    Functional EpoR pathway utilization is not detected in primary tumor cells isolated from human breast, non-small cell lung, colorectal, and ovarian tumor tissues.
    PLoS One. 2015;10:e0122149.
    PubMed     Text format     Abstract available


  211. JAMES MI, Howells LM, Karmokar A, Higgins JA, et al
    Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: trials, tribulations and a cautionary note.
    PLoS One. 2015;10:e0117776.
    PubMed     Text format     Abstract available


  212. HIDALGO-TENORIO C, Rivero-Rodriguez M, Gil-Anguita C, Esquivias J, et al
    The role of polymerase chain reaction of high-risk human papilloma virus in the screening of high-grade squamous intraepithelial lesions in the anal mucosa of human immunodeficiency virus-positive males having sex with males.
    PLoS One. 2015;10:e0123590.
    PubMed     Text format     Abstract available


  213. CHEN LX, Ning GZ, Zhou ZR, Li YL, et al
    The Carcinogenicity of Alendronate in Patients with Osteoporosis: Evidence from Cohort Studies.
    PLoS One. 2015;10:e0123080.
    PubMed     Text format     Abstract available


  214. MBANG PA, Kowalkowski MA, Amirian ES, Giordano TP, et al
    Association between Time on Protease Inhibitors and the Incidence of Squamous Cell Carcinoma of the Anus among U.S. Male Veterans.
    PLoS One. 2015;10:e0142966.
    PubMed     Text format     Abstract available


  215. YING J, Lin C, Wu J, Guo L, et al
    Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract Cancer: Implication for Targeted Therapy in Chinese Population.
    PLoS One. 2015;10:e0144731.
    PubMed     Text format     Abstract available


  216. CHATTOPADHYAY N, Berger AJ, Koenig E, Bannerman B, et al
    KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism.
    PLoS One. 2015;10:e0144825.
    PubMed     Text format     Abstract available


    January 2014
  217. GAO C, Li JT, Fang L, Xu YY, et al
    Drug allergy and the risk of lymph node metastasis in rectal cancer.
    PLoS One. 2014;9:e106123.
    PubMed     Text format     Abstract available


  218. MATHEWS WC, Agmas W, Cachay ER, Cosman BC, et al
    Natural History of Anal Dysplasia in an HIV-Infected Clinical Care Cohort: Estimates Using Multi-State Markov Modeling.
    PLoS One. 2014;9:e104116.
    PubMed     Text format     Abstract available


  219. SPENLE C, Lefebvre O, Lacroute J, Mechine-Neuville A, et al
    The laminin response in inflammatory bowel disease: protection or malignancy?
    PLoS One. 2014;9:e111336.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: